Zealand Pharma A/S
ZLDPF
$46.38
-$1.27-2.66%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 709.70M | 1.41B | 1.40B | 1.39B | 1.39B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 709.70M | 1.41B | 1.40B | 1.39B | 1.39B |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 58.30K | -917.20K |
| Gross Profit | 709.70M | 1.41B | 1.40B | 1.39B | 1.39B |
| SG&A Expenses | 77.89M | 77.06M | 75.48M | 83.18M | 67.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 200.00 | 26.62M | 29.72M | 29.72M | 29.72M |
| Total Operating Expenses | 361.48M | 379.03M | 349.44M | 310.87M | 282.52M |
| Operating Income | 348.23M | 1.03B | 1.05B | 1.08B | 1.10B |
| Income Before Tax | 430.59M | 1.05B | 1.07B | 1.09B | 1.11B |
| Income Tax Expenses | 15.20M | 83.29M | 83.15M | 87.34M | 81.26M |
| Earnings from Continuing Operations | 415.39 | 969.20 | 982.44 | 999.94 | 1.02K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 415.39M | 969.20M | 982.44M | 999.94M | 1.02B |
| EBIT | 348.23M | 1.03B | 1.05B | 1.08B | 1.10B |
| EBITDA | 352.66M | 1.03B | 1.06B | 1.09B | 1.11B |
| EPS Basic | 5.91 | 13.69 | 13.88 | 14.13 | 14.48 |
| Normalized Basic EPS | 3.70 | 9.22 | 9.29 | 9.54 | 9.70 |
| EPS Diluted | 5.86 | 13.47 | 13.66 | 13.91 | 14.25 |
| Normalized Diluted EPS | 3.67 | 9.07 | 9.14 | 9.39 | 9.55 |
| Average Basic Shares Outstanding | 281.61M | 281.99M | 282.06M | 282.44M | 282.80M |
| Average Diluted Shares Outstanding | 282.05M | 282.98M | 283.05M | 283.43M | 283.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |